Gula Koloidal
-
ʻO ka lāʻau palekana aspirin
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o polymorphisms i ʻekolu genetic loci o PEAR1, PTGS1 a me GPIIIa i nā laʻana koko holoʻokoʻa kanaka.
-
Fecal Occult Blood
Hoʻohana ʻia ke kit no ka ʻike in vitro qualitative o ka hemoglobin kanaka i nā laʻana o ka waihona kanaka a no ka ʻike mua ʻana o ke koko o ka ʻōpū.
He kūpono kēia kit no ka hoʻāʻo ʻana iā ia iho e ka poʻe ʻoihana ʻole, a hiki ke hoʻohana ʻia e nā limahana lapaʻau ʻoihana e ʻike i ke koko i loko o nā stools i nā ʻāpana olakino.
-
Kanaka Metapneumovirus Antigen
Hoʻohana ʻia kēia kit no ka ʻike qualitative o nā antigens metapneumovirus kanaka i loko o ka oropharyngeal swab, nasal swabs, a me nasopharyngeal swab samples.
-
Monkeypox Virus IgM/IgG Antibody
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o nā antibodies monkeypox virus, me IgM a me IgG, i loko o ka serum kanaka, plasma a me nā laʻana koko holoʻokoʻa.
-
Hemoglobin a me Transferrin
Hoʻohana ʻia kēia kime no ka ʻike qualitative o ka nui o ka hemoglobin kanaka a me ka transferrin i nā laʻana o ka ʻili kanaka.
-
Hoʻohui ʻia ʻo HBsAg a me HCV Ab
Hoʻohana ʻia ka pahu no ka ʻike kūpono o ka hepatitis B surface antigen (HBsAg) a i ʻole hepatitis C virus antibody i loko o ke kanaka serum, plasma a me ke koko holoʻokoʻa, a he kūpono ia no ke kōkua ʻana i ka hōʻailona o nā maʻi i manaʻo ʻia he maʻi HBV a i ʻole ka nānā ʻana i nā hihia ma nā wahi me ka nui o ka maʻi.
-
ʻO SARS-CoV-2, Influenza A&B Antigen, Respiratory Syncytium, Adenovirus a me Mycoplasma Pneumoniae i hui pū ʻia.
Hoʻohana ʻia kēia kit no ka ʻike qualitative o SARS-CoV-2, influenza A&B antigen, Respiratory Syncytium, adenovirus a me mycoplasma pneumoniae i loko o ka nasopharyngeal swab, oropharyngeal swaband nasal swab samples in vitro, a hiki ke hoʻohana ʻia no ka hōʻailona ʻokoʻa o ka maʻi coronavirus novel, respiratory syncytial virus maʻi a me ka maʻi maʻi B. ʻO nā hopena hoʻāʻo wale nō no ka hōʻike lapaʻau, ʻaʻole hiki ke hoʻohana ʻia ma ke kumu hoʻokahi no ka maʻi a me ka mālama ʻana.
-
ʻO SARS-CoV-2, Respiratory Syncytium, a me Influenza A&B Antigen Combined
Hoʻohana ʻia kēia kit no ka ʻike qualitative o SARS-CoV-2, respiratory syncytial virus a me ka influenza A&B antigens in vitro, a hiki ke hoʻohana ʻia no ka maʻi ʻokoʻa o ka maʻi SARS-CoV-2, respiratory syncytial virus maʻi, a me ka maʻi maʻi influenza A a i ʻole B [1]. ʻO nā hopena hoʻāʻo no ka hōʻike lapaʻau wale nō a ʻaʻole hiki ke hoʻohana ʻia ma ke kumu hoʻokahi no ka maʻi a me ka mālama ʻana.
-
OXA-23 Carbapenemase
Hoʻohana ʻia kēia kit no ka ʻike qualitative o OXA-23 carbapenemases i hana ʻia i nā laʻana bacterial i loaʻa ma hope o ka moʻomeheu in vitro.
-
ʻO Clostridium Difficile Glutamate Dehydrogenase(GDH) a me Toxin A/B
Hoʻolālā ʻia kēia pahu no ka ʻike in vitro qualitative o Glutamate Dehydrogenase(GDH) a me Toxin A/B i nā laʻana o nā mea i manaʻo ʻia he clostridium difficile.
-
Carbapenemase
Hoʻohana ʻia kēia kit no ka ʻike qualitative o NDM, KPC, OXA-48, IMP a me VIM carbapenemases i hana ʻia i nā laʻana bacterial i loaʻa ma hope o ka moʻomeheu in vitro.
-
HCV Ab hōʻike pahu
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i nā antibodies HCV i loko o ke kanaka serum/plasma in vitro, a ua kūpono ia no ka hōʻoia kōkua o nā maʻi i manaʻo ʻia he maʻi HCV a i ʻole ka nānā ʻana i nā hihia ma nā wahi me ka nui o ka maʻi maʻi.
